By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


H3 Biomedicine Inc. 

300 Technology Square, Fifth Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-252-5000 Fax: n/a


Company News
H3 Biomedicine’s Preclinical Data Highlighting Novel Discovery Research Around Splicing Modulators Published In Current Issue Of Nature Communications 6/1/2017 6:27:49 AM
H3 Biomedicine Appoints Lihua Yu, Ph.D., To Chief Data Sciences Officer 5/1/2017 6:02:04 AM
H3 Biomedicine Extends Collaboration With Foundation Medicine, Inc. (FMI) To Develop Precision Therapies For Cancer 4/20/2017 6:13:03 AM
H3 Biomedicine Presents New Data From Its RNA Splicing Platform At AACR 4/4/2017 7:19:41 AM
H3 Biomedicine Announces Appointment Of Peter G. Smith, Ph. D., To Chief Scientific Officer 2/21/2017 8:27:16 AM
H3 Biomedicine Announces Data From Lead Development Program Of H3B-8800 In Pre-Clinical Models Of Hematologic Cancers 12/6/2016 12:21:04 PM
Cancer Genetics (CGIX) Selected By H3 Biomedicine To Provide Biomarker Discovery And Testing For A Global Drug Development Program In Hematologic Cancers 7/18/2016 8:03:16 AM
H3 Biomedicine Announces Appointment Of Tarek Sahmoud As Chief Medical Officer 6/1/2016 4:44:38 PM
H3 Biomedicine Receives FDA Acceptance For Investigational New Drug Application 5/11/2016 10:36:33 AM
H3 Biomedicine To Present Data On SF3B1 Program At 2015 American Society of Hematology Meeting 12/4/2015 10:50:59 AM